Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.

Cammà, C.; Bruno, S.; Schepis, Filippo; Iacono, O. L.; Andreone, P.; Gramenzi, A. G.; Mangia, A.; Andriulli, A.; Puoti, M.; Spadaro, A.; Freni, M.; Marco, V. D.; Cino, L.; Saracco, G.; Chiesa, A.; Crosignani, A.; Caporaso, N.; Morisco, F.; Rumi, M. G.; Craxì, A.

BACKGROUND AND AIMS: Retreatment with a combination of alpha interferon (IFN) plus ribavirin of patients with chronic hepatitis C who did not respond to IFN monotherapy has not been assessed in large controlled studies. METHODS: To assess the effectiveness and tolerability of IFN/ribavirin retreatment of non-responders to IFN and to identify predictors of complete (biochemical and virological) sustained response, we performed a meta-analysis of individual data on 581 patients from 10 centres. Retreatment with various IFN schedules (mean total dose 544 mega units) and a fixed ribavirin dose (1000-1200 mg/daily depending on body weight) was given for 24-60 (mean 39.5) weeks. RESULTS: Biochemical end of treatment and sustained responses were observed in 271/581 (46.6\%; 95\% confidence interval (CI) 42.6-50.7\%) and in 109/581 (18.7\%; 95\% CI 15.6-22.0\%) cases, respectively. Two hundred and six of 532 patients (38.7\%; 95\% CI 34.6-42.9\%) had an end of treatment complete response to retreatment while a complete sustained response occurred in 88 of 559 (15.7\%; 95\% CI 12.8-18.8\%). Fifty four of 581 patients (9.2\%; 95\% CI 7.0-11.7\%) stopped retreatment due to adverse effects. By logistic regression, complete sustained response was predicted independently by age <45 years (p=0.04), by normal pretreatment gamma-glutamyltransferase levels (p=0.01), and by a second course total IFN dose of at least 432 mega units (p=0.008). CONCLUSIONS: The overall low probability of effectiveness argues against indiscriminate retreatment of all IFN monotherapy non-responders with IFN/ribavirin. Patients less than 45 years old with normal gamma-glutamyltransferase levels who were retreated with high dose long course combination therapy had a complete sustained response rate of 30\%.

Data di pubblicazione:	2002
Titolo:	Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.
Autore/i:	C. Cammà;S. Bruno;F. Schepis;O. L. Iacono;P. Andreone;A. G. Gramenzi;A. Mangia;A. Andriulli;M. Puoti;A. Spadaro;M. Freni;V. D. Marco;L. Cino;G. Saracco;A. Chiesa;A. Crosignani;N. Caporaso;F. Morisco;M. G. Rumi;A. Craxì
Autore/i UNIMORE:	C. Cammà S. Bruno SCHEPIS, Filippo O. L. Iacono P. Andreone A. G. Gramenzi A. Mangia A. Andriulli M. Puoti A. Spadaro M. Freni V. D. Marco L. Cino G. Saracco A. Chiesa A. Crosignani N. Caporaso F. Morisco M. G. Rumi A. Craxì mostra contributor esterni nascondi contributor esterni
Rivista:	GUT
Volume:	51
Pagina iniziale:	864
Pagina finale:	869
Codice identificativo ISI:	WOS:000179385900024
Codice identificativo Scopus:	2-s2.0-0036896655
Codice identificativo Pubmed:	12427791
Citazione:	Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data / C. Cammà;S. Bruno;F. Schepis;O. L. Iacono;P. Andreone;A. G. Gramenzi;A. Mangia;A. Andriulli;M. Puoti;A. Spadaro;M. Freni;V. D. Marco;L. Cino;G. Saracco;A. Chiesa;A. Crosignani;N. Caporaso;F. Morisco;M. G. Rumi;A. Craxì. - In: GUT. - ISSN 0017-5749. - STAMPA. - 51(2002), pp. 864-869.
Tipologia	Articolo su rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11380/641255

Citazioni

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris